Cost-effective screening for cervical cancer in Chennai

The population-based screening method can be employed even in primary health centres.

July 31, 2014 08:47 am | Updated 11:28 am IST - CHENNAI

V. Shanta, chairperson of Cancer Institute, Adyar having a word with Dev Ohri (left),managing director of Thermo Fisher Life Science Solutions at the Ion Torrent PGM Unit to the institute handed over function held in Chennai on Wednesday, Jagdeep Sehgal, director, Instrument and Diagnostics, Thermo Fisher Life Science Solutions is in the picture. Photo: B. Jothi Ramalingam

V. Shanta, chairperson of Cancer Institute, Adyar having a word with Dev Ohri (left),managing director of Thermo Fisher Life Science Solutions at the Ion Torrent PGM Unit to the institute handed over function held in Chennai on Wednesday, Jagdeep Sehgal, director, Instrument and Diagnostics, Thermo Fisher Life Science Solutions is in the picture. Photo: B. Jothi Ramalingam

The Department of Molecular Oncology of Cancer Institute has developed a modified Elisa technique to enable population-based cervical cancer screening in a cost-effective manner. It has filed for a patent and is in the process of transferring the technology to a Government of India subsidiary company.

T. Rajkumar, head of Molecular Oncology, said conventionally, the pap smear test is being used for screening women for cervical cancer. “We need highly trained pathologists or cytologists for diagnosis and there are not many in the country. Hence, the Government of India decided that pap smear cannot apply for a population-based screening,” he said at a function to hand over the Ion Torrent PGM Unit to the institute on Wednesday. As of now, village health nurses were trained to detect abnormal cervix by visual inspection with acetic acid. He said this was low-cost but had problems of low sensitivity.

“We have developed Double Antibody Sandwich Elisa for detection of p16 – a protein that forms after Human Papillomavirus infection is established. It can be done at the point of care such as primary health centres,” he explained. This can help in early diagnosis of cervical cancer, even in the pre-cancerous stage.

V. Shanta, chairperson of Cancer Institute, said Thermo Fisher Life Science Solutions, represented on the occasion by its managing director, Dev Ohri, was donating the Ion Torrent PGM Unit costing Rs. 75 lakh as part of its corporate social responsibility.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.